Now that the level of concern for a toxic blood lead concentration is 0.482 moI/L (10 gIdL), laboratories must meet new requirements to shorten analysis times and increase accuracy and precision of blood lead determinations. We used a matrix-matching method to estimate the lead concentration in blood by graphite furnace atomic absorption spectroscopy (GFAAS). For CDC proficiency samples and the NIST-Certified Blood Reference stan- 
those >1.93 jmoWL (4).
Analysis of whole blood for lead is generally done with either graphite furnace atomic absorption spectroscopy (GFAAS) or anodic stripping voltammetry (ASV). A recent CDC proficiency summary showed that 69% of participating laboratories used GFAAS and 23% used ASV for the analysis of lead in whole-blood samples (4).
Other methods (5) (6) (7) (8) either have not been well established or, like ASV, do not lend themselves easily to automation.
Recent efforts by other researchers to increase the accuracy of either ASV or GFAAS have involved increases in sample preparation time (9) or data-analysis time (10). Our current GFAAS technologr can use aqueous standards for calibration (11), which is fast and adequate for screening, but we wanted a method with improved accuracy and precision over that in previously published work, particularly at lower concentrations. The ASV method has been the method of analysis for blood specimens drawn in the weekly lead clinics at the Kennedy Krieger Institute for nearly 20 years. During this time, our laboratory has been participating successfully in external proficiency programs and has served as a reference laboratory for several of these programs.
We have now developed a method for blood lead measurement with our graphite furnace instrument; our approach is based on currently used methods (12, 13), into which we have introduced a novel technique for calibration.
Here we report our comparison of this method with established methods, in terms of performance in an external proficiency testing program and according to previously published GFAAS studies. We also assessed method performance with human blood samples and compared the results with those by ASV for the same set of samples.
MaterIals and Methods Apparatus
We used a Zeeman/5 100 PC atomic absorption spectrophotometer with HGA-600 graphite 
Sample Collectionand Storage
Human blood samples were drawn from children who had been referred to the lead clinic at Kennedy Krieger Institute.
The blood samples were taken as part of a routine weekly lead clinic held at the Institute, and sampling adhered to the policy and protocols outlined by Kennedy Krieger Institute.
Venous blood samples were collected into purple-cap (EDTA-containing)
Vacutainer Tubes (Becton Dickinson, Rutherford, NJ) after scrubbing of the arm with alcohol swabs followed by venipuncture.
The collected samples were analyzed within the hour by ASV (which was available on-site) and later by GFAAS (in a different location).
Between these analyses, samples were stored at -20#{176}C.
Procedures
Glasswashing procedure.
To ensure lead-free glassware/plasticware, we washed our containers with Acationox detergent, then soaked them in dilute (250 milL) nitric acid overnight. After soaking, the glassware was rinsed with deionized water (Hydro, Research Triangle Park, NC; prepared by reverse osmosis with two polishing columns) and air-dried until used. On the Digiflex pipette the left syringe was set to 300 hL and the right syringe to 100 L; these settings were used to dilute (10-fold) the well-mixed low-lead blood into disposable culture tubes with caps, which were vortex-mixed for 10-20 s until the blood cells were completely lysed. The diluted blood was then used in the preparation of calibration standards each week as follows. Stock solutions of lead-SO, 100, 300, 400, and 500 gfL prepared in 2 milL nitric acid-were diluted 10-fold with the diluted, lysed blood in 2-mL autosampler cups and vortex-mixed.
The resulting calibration standards had concentrations of 5 + n, 10 + n, 30 + n, 40 + n, and 50 + n g/L, where n was the concentration of the diluted low-lead blood. The characteristic mass value (mo) for the instrument and the measured absorbance of the low-lead blood sample were used to calculate the value of the base blood, [ni. The base blood was from blood samples delivered to the laboratory either frozen or fresh; samples were thawed if necessary and vortexmixed thoroughly for 10 s before dilution with matrixmodifier solution.
Before calibration, the instrument was autozeroed with the matrix-modifier solution as the blank. We assumed that m0 remained fairly constant from day to day. For instance, the lead m0 for this 
Quality Control

After calibration
we used NIST 955a samples, one high concentration and one low, for continuing verification of linearity.
The low standard was 0.242 moI/L (5.01 g/dL) until our supply of this standard was exhausted, after which we used an equivolume dilution of the 0.653 .tmo]/L (13.53 g/dL) standard (i.e., a 0.327 zmol/L low standard).
Our high standard was 1.478 moI/L (30.63 1.g/dL). Low and high standards were analyzed after calibration and after every four sample determinations.
Our requirement for process control was a measured value within 0.097 mol/L (±2 g/dL) of the certified value for each high and low qualitycontrol sample.
Results
The individual
lead concentration values for the 52 proficiency blood samples analyzed by ASV and GFAAS are plotted with their fitted least squares regression lines in Fig. 1 The GFAAS method is more precise than the ASV method, according to an F-test for common variance between two samples (homogeneity of variance test).
Ref. 4 (P <0.001) indicates that the GFAAS method is more precise (less variable) than the ASV method.
Moreover, 87% of measured values were within 0.048 /.LmoI/L (± 1 g/dL) of the consensus value by the new GFAAS method vs 52% by the ASV method (see Table  2 ). The relative standard deviations (CV) for replicate analyses of three certified blood lead standards by GFAAS are listed in Table 3 
Discussion
The new method performed well compared with previously published graphite furnace methods (9, 12, 13) (see Table 4 ). Although the methods listed in Table 4 used a variety of replicates for determining precision, our method compares well with all of them both in accuracy and precision. In particular, the within-run precision and accuracy of our method shows that low concentrations of lead in blood can be measured with improved accuracy and precision. Although other methods of establishing the concentration of lead in the base blood could be used, e.g., standard additions or thermal ionization mass spec- however, our method should allow improved precision and accuracy and perhaps less dependence on very low concentrations of blood lead for calibration, because the value of the lowlead blood used to make up the calibrators will be included in the calibration line.
Overall, the GFAAS method had better precision and took a shorter analytical time than did ASV, although newer-generation ASVs will probably show improved performance in time and precision. We found no evidence of systematic biases between the two methods on a set of 39 clinical blood samples ranging from 0.097 to 2.220 /.LmoI/L (2-46 g/dL); thus, like ASV, the GFAAS method could be used to provide a rapid analysis in a clinical setting.
In conclusion, we present a method that has better performance characteristics than those of an established ASV method, has a matrix-based method of calibration, and has the ability to meet both clinical and research needs for improved blood lead measurement at low concentrations. This is especially critical where research into the subclinical effects of low concentrations of blood lead on children is being undertaken. We have used the method for 9 months with a history of good performance in the CDC proficiency program, in which 24 of 27 measurements within the range 0.097-2.799 jimol/L (2-58 g/dL) fell within 0.048 /LmolJL (1 g/dL) of the consensus values.
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